A kind of nanoparticle targeting whole-body multilevel lymph nodes, preparation method and application
A nanoparticle and lymph node technology, applied in the fields of biological science and drug carriers, can solve the problems of indistinguishable dark part angiography, and achieve the effects of deep-level targeted angiography, simple preparation process, and excellent physical and chemical properties.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Example 1: Nanoparticles Targeting Systemic Multilevel Lymph Nodes
[0044] An embodiment of the present invention provides a nanoparticle targeting multilevel lymph nodes throughout the body, see Figure 5 As shown, nanoparticles include phospholipids, lipiodol, optical probes, and alpha-helical polypeptides. Phospholipid is one or more of DMPC, MHPC, DMPE, DSPE-PEG2000. The optical probe is a water-soluble optical probe or a fat-soluble optical probe. The water soluble optical probe is ICG. The α-helical polypeptide sequence is FAEKFKEAVKDYFAKFWD or a polypeptide containing the FAEKFKEAVKDYFAKFWD sequence. The amino acid sequence of the α-helical polypeptide is shown in SEQ ID NO.1 in the sequence listing. seefigure 1 As shown in the electron microscope schematic diagram of the nanoparticles, the size distribution of the nanoparticles is uniform. see figure 2 As shown in the particle size distribution diagram of the nanoparticles, the particle size of the nanop...
Embodiment 2
[0045] Example 2: Preparation of nanoparticles encapsulating water-soluble optical probe ICG and lipiodol
[0046] The embodiment of the present invention provides a preparation method of nanoparticles targeting multi-level lymph nodes in the whole body:
[0047] A1. Dissolve DMPC, MHPC, DMPE, DSPE-PEG2000 and lipiodol in a mixture of chloroform and methanol (volume ratio 2:1); in terms of parts by mass, DMPC is 6-8 parts, and MHPC is 1.5-2 parts , 2.5 to 3.5 parts of DMPE, 2.5 to 3.5 parts of DSPE-PEG2000, and 30 to 35 parts of lipiodol.
[0048] A2, vacuum drying
[0049] Place the mixed solution in step A1 in a round-bottomed flask, ultrasonicate in a water bath for 30s; then use a vacuum pump to extract the organic solvent, and stir with a magnetic stirrer while vacuuming; continue drying for 2 hours until the organic solvent is completely extracted;
[0050] A3, water bath
[0051] Place the round-bottomed flask extracted in step A2 in water at 50°C, and continue the w...
Embodiment 3
[0060] Example 3: Preparation of nanoparticles encapsulating fat-soluble optical probe DiR-BOA and lipiodol
[0061] Steps refer to Example 2, the difference is that DiR-BOA is added to A1, wherein the α-helical polypeptide is 2 to 4 parts by mass, and the DiR-BOA is 0.24 to 0.3 parts, and the DiR -BOA was wrapped into nanoparticles, concentrated, purified in A7, and set aside.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com